0R15 9025.0 0.0% 0R1E 9410.0 0.0% 0M69 None None% 0R2V 247.99 9682.643% 0QYR 1567.5 0.0% 0QYP 439.3701 -2.9016% 0RUK None None% 0RYA 1597.0 1.2682% 0RIH 195.55 0.0% 0RIH 191.4 -2.1222% 0R1O 225.5 9683.0803% 0R1O None None% 0QFP 10475.8496 107.8542% 0M2Z 252.573 0.2373% 0VSO 33.0 -7.3164% 0R1I None None% 0QZI 622.0 0.0% 0QZ0 220.0 0.0% 0NZF None None% 0YXG 222.05 -4.1318%

ALK-Abello B

GB 0OIR

159.2009GBP
9.75(6.52%)

Last update at 2024-12-18T08:00:00Z

Day Range

149.60162.70
LowHigh

52 Week Range

70.40149.45
LowHigh

Fundamentals

  • Previous Close 149.45
  • Market Cap27711.19M
  • Volume20598
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA808.00M
  • Revenue TTM4728.00M
  • Revenue Per Share TTM21.29
  • Gross Profit TTM 2822.00M
  • Diluted EPS TTM-

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax - - 101.00M -31.00000M -103.00000M
Minority interest - - - - -
Net income - - 25.00M -50.00000M -170.00000M
Selling general administrative - - 1295.00M 1378.00M 1311.00M
Selling and marketing expenses - - - - -
Gross profit - - 2028.00M 1892.00M 1633.00M
Reconciled depreciation - - - - -
Ebit 501.00M 310.00M 174.00M -4.00000M -86.00000M
Ebitda - - - - -
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income - - 150.00M -14.00000M -96.00000M
Other operating expenses 1.00M 1.00M 1.00M 1.00M 1.00M
Interest expense - 0.00000M 0.00000M 0.00000M 0.00000M
Tax provision - - 76.00M 19.00M 67.00M
Interest income - - 45.00M 18.00M 10.00M
Net interest income - - - - -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 112.00M 60.00M 76.00M 19.00M 67.00M
Total revenue - - 3491.00M 3274.00M 2915.00M
Total operating expenses - - - - -
Cost of revenue - - 1463.00M 1382.00M 1282.00M
Total other income expense net - - - - -
Discontinued operations - - - - -
Net income from continuing ops - - - - -
Net income applicable to common shares 335.00M 219.00M 25.00M -50.00000M -170.00000M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets - - 5563.00M 5495.00M 4865.00M
Intangible assets - - 172.00M 221.00M 260.00M
Earning assets - - - - -
Other current assets - - - - -
Total liab - - 2410.00M 2319.00M 1686.00M
Total stockholder equity - - 3153.00M 3176.00M 3179.00M
Deferred long term liab - - - - -
Other current liab 262.00M 192.00M 176.00M 804.00M 574.00M
Common stock 111.00M 111.00M 111.00M 111.00M 111.00M
Capital stock - - - - -
Retained earnings 3857.00M 3410.00M 3167.00M 3084.00M 3110.00M
Other liab 492.00M 536.00M 488.00M 444.00M 235.00M
Good will - - 452.00M 461.00M 465.00M
Other assets 1003.00M 991.00M 895.00M 826.00M 548.00M
Cash - - - - -
Cash and equivalents - - - - -
Total current liabilities 1399.00M 1385.00M 1029.00M 934.00M 726.00M
Current deferred revenue - - - - -
Net debt - - - - -
Short term debt - - - - -
Short long term debt - - - - -
Short long term debt total - - 893.00M 941.00M 725.00M
Other stockholder equity 20.00M -41.00000M -125.00000M -19.00000M -42.00000M
Property plant equipment 2018.00M 1814.00M 1704.00M 1739.00M 1584.00M
Total current assets 2645.00M 2403.00M 2340.00M 2248.00M 1999.00M
Long term investments - - - - -
Net tangible assets 3346.00M 2858.00M 2529.00M 2494.00M 2454.00M
Short term investments - - - - 100.00M
Net receivables 888.00M 691.00M 684.00M 665.00M 527.00M
Long term debt - - 686.00M 707.00M 724.00M
Inventory 1297.00M 1204.00M 1093.00M 1056.00M 993.00M
Accounts payable 131.00M 115.00M 74.00M 81.00M 135.00M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total - - - - -
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments 2.00M -3.00000M -23.00000M 1.00M 1.00M
Change to liabilities 11.00M 61.00M 74.00M 159.00M 67.00M
Total cashflows from investing activities -351.00000M -266.00000M -245.00000M -157.00000M -199.00000M
Net borrowings -73.00000M -270.00000M -49.00000M -44.00000M -18.00000M
Total cash from financing activities -42.00000M -311.00000M -62.00000M -57.00000M -28.00000M
Change to operating activities - - - - -74.00000M
Net income 335.00M 219.00M 25.00M -50.00000M -170.00000M
Change in cash 27.00M -104.00000M -18.00000M -80.00000M -315.00000M
Begin period cash flow - - - - -
End period cash flow - - - - -
Total cash from operating activities 416.00M 468.00M 301.00M 132.00M -95.00000M
Issuance of capital stock - - - - -
Depreciation 204.00M 188.00M 173.00M 192.00M 164.00M
Other cashflows from investing activities - - -23.00000M 10.00M -21.00000M
Dividends paid - - - - -
Change to inventory -74.00000M -84.00000M -69.00000M -54.00000M -102.00000M
Change to account receivables -172.00000M -5.00000M -159.00000M -200.00000M -39.00000M
Sale purchase of stock - - -13.00000M -13.00000M -10.00000M
Other cashflows from financing activities -11.00000M -72.00000M -24.00000M -24.00000M -18.00000M
Change to netincome 80.00M 55.00M 223.00M 52.00M -44.00000M
Capital expenditures 298.00M 218.00M 196.00M 147.00M 126.00M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital - - -168.00000M -106.00000M -231.00000M
Stock based compensation - - - - -
Other non cash items - - - - -
Free cash flow - - - - -

Peer Comparison

Sector: Industry:

Company Change (GBP) Price (GBP) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x)
0OIR
ALK-Abello B
9.75 6.52% 159.20 - - - -
0RIH
Alphabet Inc Class A
- -% 195.55 - - - -
0QFP
Gedeon Richter PLC
5435.85 107.85% 10475.85 - - - -
0M2Z
Equinor ASA
0.60 0.24% 252.57 - - - -
0VSO
BYD Co. Ltd.
-2.605 7.32% 33.00 - - - -

Reports Covered

Stock Research & News

Profile

ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. Its product portfolio includes GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDACURE, and ITULAZAX for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including grass, ragweed, house dust mite, Japanese cedar, tree, and food. It also provides consumer healthcare solution, which include Digital eco-system, a platform which connect and engages with allergy sufferers much earlier in the disease journey through tools and e-commerce offerings that supports, guidance and relief, and smoothing the path to allergy immunotherapy treatment. In addition, the company offers diagnostic allergy solutions through testing by skin prick test or blood test; and emergency treatment, such as intramuscular injection of adrenaline for the treatment of acute life-threatening allergic reactions including Anaphylaxis. The company has a collaboration with Torii Pharmaceutical Co., Ltd. to develop, market and distribute allergy immunotherapy tablet for the treatment of grass pollen allergy. ALK-Abelló A/S was founded in 1923 and is headquartered in Horsholm, Denmark.

ALK-Abello B

Boge Alle 6-8, Horsholm, Denmark, 2970

Key Executives

Name Title Year Born
Mr. Carsten Hellmann Pres, CEO & Member of Management Board 1964
Mr. Soren Jelert Group CFO, Exec. VP & Member of Management Board 1972
Mr. Henrik Jacobi Exec. VP of R&D and Member of Board of Management 1965
Mr. Søren Daniel Niegel Exec. VP of Commercial Operations & Member of Management Board 1971
Ms. Katja Barnkob Thalund Project Director of Global CMC Devel. & Employee-elected Director 1969
Mr. Per Plotnikof VP of Corp. Communications, Investor Relations & Strategic Planning and Head of IR NA
Prof. Hendrik Kees Kam Nolte M.D., Ph.D. Sr. VP of Research & Devel. - North America and International Markets NA
Mr. Christian G. Houghton Head of Product Supply NA
Mr. Miles Guralnick Pres of ALK Abelló Source Materials Inc NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions